Loading clinical trials...
Loading clinical trials...
Development of a Population Pharmacokinetic Model to Optimize Tacrolimus Dosing in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplant.
Conditions
Interventions
Tacrolimus
Locations
1
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Start Date
February 1, 2021
Primary Completion Date
October 15, 2023
Completion Date
October 15, 2023
Last Updated
October 17, 2023
NCT02611180
NCT03701698
NCT02806947
NCT01530256
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions